Haemato Oncology Foundation for Adults in the Netherlands Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2016
NCT02688140
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 3)

Leukemia, Promyelocytic, Acute (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 7